EFG Asset Management (Americas)’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.69M | Buy |
5,775
+183
| +3% | +$111K | 0.64% | 50 |
|
|
2025
Q2 | $3M | Sell |
5,592
-301
| -5% | -$144K | 0.55% | 57 |
|
|
2025
Q1 | $2.47M | Sell |
5,893
-144
| -2% | -$62.5K | 0.5% | 59 |
|
|
2024
Q4 | $2.5M | Sell |
6,037
-4,951
| -45% | -$2.17M | 0.49% | 69 |
|
|
2024
Q3 | $5.55M | Sell |
10,988
-1,740
| -14% | -$845K | 1.09% | 32 |
|
|
2024
Q2 | $6.2M | Buy |
12,728
+3,966
| +45% | +$1.99M | 1.22% | 26 |
|
|
2024
Q1 | $4.73M | Sell |
8,762
-3,593
| -29% | -$1.96M | 1.44% | 22 |
|
|
2023
Q4 | $6.86M | Sell |
12,355
-588
| -5% | -$276K | 1.48% | 19 |
|
|
2023
Q3 | $5.67M | Buy |
12,943
+102
| +0.8% | +$50.9K | 1.36% | 24 |
|
|
2023
Q2 | $6.45M | Sell |
12,841
-344
| -3% | -$165K | 1.49% | 18 |
|
|
2023
Q1 | $6.59M | Sell |
13,185
-4,344
| -25% | -$2.08M | 1.58% | 18 |
|
|
2022
Q4 | $7.15M | Buy |
17,529
+5,327
| +44% | +$2.07M | 1.77% | 15 |
|
|
2022
Q3 | $3.98M | Buy |
12,202
+60
| +0.5% | +$22K | 1.01% | 32 |
|
|
2022
Q2 | $4.26M | Sell |
12,142
-443
| -4% | -$181K | 1.01% | 34 |
|
|
2022
Q1 | $6.89M | Sell |
12,585
-2,668
| -17% | -$1.4M | 1.28% | 29 |
|
|
2021
Q4 | $10.1M | Buy |
15,253
+449
| +3% | +$282K | 1.69% | 20 |
|
|
2021
Q3 | $9.22M | Sell |
14,804
-1,132
| -7% | -$761K | 1.64% | 20 |
|
|
2021
Q2 | $10.1M | Sell |
15,936
-816
| -5% | -$451K | 1.87% | 15 |
|
|
2021
Q1 | $8.2M | Sell |
16,752
-7,467
| -31% | -$3.74M | 1.68% | 18 |
|
|
2020
Q4 | $12.1M | Sell |
24,219
-1,303
| -5% | -$583K | 2.48% | 5 |
|
|
2020
Q3 | $10M | Sell |
25,522
-1,796
| -7% | -$664K | 2.25% | 6 |
|
|
2020
Q2 | $9.02M | Buy |
27,318
+14,483
| +113% | +$4.19M | 2.34% | 7 |
|
|
2020
Q1 | $3.11M | Sell |
12,835
-1,945
| -13% | -$508K | 1% | 35 |
|
|
2019
Q4 | $3.86M | Sell |
14,780
-1,483
| -9% | -$391K | 1.02% | 38 |
|
|
2019
Q3 | $4.42M | Sell |
16,263
-2,202
| -12% | -$613K | 1.33% | 27 |
|
|
2019
Q2 | $5.08M | Sell |
18,465
-1,302
| -7% | -$321K | 1.45% | 19 |
|
|
2019
Q1 | $4.42M | Sell |
19,767
-694
| -3% | -$143K | 1.34% | 23 |
|
|
2018
Q4 | $3.81M | Buy |
20,461
+3,119
| +18% | +$639K | 1.37% | 22 |
|
|
2018
Q3 | $4.33M | Buy |
17,342
+5,121
| +42% | +$1.24M | 1.24% | 26 |
|
|
2018
Q2 | $2.66M | Buy |
12,221
+7,517
| +160% | +$1.55M | 0.81% | 40 |
|
|
2018
Q1 | $900K | Sell |
4,704
-406
| -8% | -$74.9K | 0.37% | 62 |
|
|
2017
Q4 | $799K | Buy |
5,110
+1,854
| +57% | +$292K | 0.29% | 73 |
|
|
2017
Q3 | $506K | Buy |
3,256
+1,359
| +72% | +$215K | 0.19% | 85 |
|
|
2017
Q2 | $306K | Buy |
+1,897
| New | +$308K | 0.12% | 113 |
|
Other funds holding IDXX
EFG Asset Management (Americas)'s IDXX Position: Q3 2025 in Review
EFG Asset Management (Americas) increased its Idexx Laboratories (IDXX) stake by 3.3% in Q3 2025, buying an estimated $111K and bringing the position to 5,775 shares worth $3.69M. The position accounts for 0.64% of the portfolio, ranked #50.
EFG Asset Management (Americas) first reported a position in IDXX in Q2 2017 and has held it in 34 quarters since. The position peaked at $12.1M in Q4 2020. 1,303 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.
- EFG Asset Management (Americas) held 5,775 shares of Idexx Laboratories worth $3.69M as of Q3 2025.
- EFG Asset Management (Americas) bought 183 Idexx Laboratories shares in Q3 2025, an estimated $111K.
- Idexx Laboratories made up 0.64% of EFG Asset Management (Americas)'s portfolio in Q3 2025, its #50 holding.
- EFG Asset Management (Americas) first reported a position in Idexx Laboratories in Q2 2017 and has held it in 34 quarters since.
- EFG Asset Management (Americas)'s Idexx Laboratories position peaked at $12.1M in Q4 2020.
- 1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.
Based on EFG Asset Management (Americas)'s 13F filing for Q3 2025, filed 14 Nov 2025.